RE:Drop since FDA approval actually 50%When trading resumed after hours, it started at $7.03 and fallen to a low of $3.52.
50% drop since FDA announcement. Doesn't seem logical with a drug approval and a PRV.
I assume that selling the drug line and 30% of the PRV for $5M is being considered a dumb move. Also, sold plasma collection facilities for $17M. There is nothing left except the cash which LMNL will blow through in a year easy.
LOL Sold 30% of PRV (thats a $30M value) for $5M only two weeks before approval. Through in Ryplazim for nothing (LMNL's only revenue).